Form 8-K - Current report:
SEC Accession No. 0001493152-20-016677
Filing Date
2020-08-25
Accepted
2020-08-25 16:07:19
Documents
2
Period of Report
2020-07-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 31617
2 ex10-1.htm EX-10.1 103664
  Complete submission text file 0001493152-20-016677.txt   136466
Mailing Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901
Business Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901 2153450919
ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)

EIN.: 232577138 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21617 | Film No.: 201132332
SIC: 2834 Pharmaceutical Preparations